Trial Profile
A Study to Evaluate the Efficacy of Defibrotide in Patients With Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome following Hematopoietic Stem Cell Transplantation (HSCT)
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 23 Jan 2019
Price :
$35
*
At a glance
- Drugs Defibrotide (Primary)
- Indications Hepatic veno-occlusive disease
- Focus Adverse reactions; Expanded access; Therapeutic Use
- 04 Dec 2018 Results (n=991) presented at the 60th Annual Meeting and Exposition of the American Society of Hematology
- 25 Jun 2017 Results of subgroup analysis (n=1000) presented at the 22nd Congress of the European Haematology Association
- 25 Jun 2017 Results of a post hoc analysis presented at the 22nd Congress of the European Haematology Association